Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Hair Loss Updates Every Dermatologist Should Know in 2025
Description
In 2025, dermatologists are encouraged to stay updated on hair loss treatments, particularly the rise of scalp spas in the U.S., which offer wellness experiences through services like scalp facials and laser treatments, often without physician oversight. While these spas are growing in popularity, it is essential for dermatologists to engage with this trend to ensure treatment is evidence-based and safe. New technologies include non-ablative devices for painless monthly treatments, ultrasound systems with growth factor serums, and 1927 thulium lasers combined with proprietary serums, although research backing some of these methods remains limited. The consensus guidelines for oral minoxidil have also evolved, emphasizing safety screenings before prescribing, with recommendations for starting dosages and gradual discontinuation. The guidelines suggest monitoring heart health and considering cessation three months prior to pregnancy for women, marking a significant shift in protocol. Overall, dermatologists are encouraged to incorporate these advancements into their practice while ensuring patient safety and regulatory compliance.
View moreConclusions
- The rise of scalp spas in the U.S. indicates a growing trend in consumer demand for hair wellness services.
- Scalp treatments often utilize non-standard, wellness-focused techniques rather than evidence-based medicine.
- Dermatologists should consider integrating scalp treatments into their practice for both patient benefit and revenue potential.
- Emerging technologies, such as non-ablative devices and ultrasound for growth factor delivery, show promise but lack robust peer-reviewed data.
- Low-dose oral minoxidil has shown effectiveness for hair loss, but patient screening for contraindications is vital.
- Consensus guidelines recommend careful monitoring and management strategies for patients on low-dose oral minoxidil, including gradual discontinuation.
- Dermatologists should be aware of the importance of standardizing scalp treatments based on clinical evidence to ensure safety and efficacy.
- * Alessandrini AM et al. Dermatol Pract Concept. 2021 May 20;11(3):e2021082. doi: 10.5826/dpc.1103a82. PMID: 34123571; PMCID: PMC8172030.
- Multicenter Study > J Am Acad Dermatol. 2021 Jun;84(6):1644-1651. doi: 10.1016/j.jaad.2021.02.054. Epub 2021 Feb 24. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients
- David Saceda-Corralo, MD, PhD · Daniel Ortega-Quijano, MD · Diego Fernandez-Nieto, MD · Sergio Vaño-Galvan, MD, PhD. Published: August 13, 2022 · DOI: https://doi.org/10.1016/j.jaad.2022.06.1205
- Low-dose Oral Minoxidil in the Treatment of Alopecia: Evidence and Experience-based Consensus: Statement of Indian Experts.